Veedol Corporation Limited (NSE:VEEDOL)
1,502.50
-7.90 (-0.52%)
Aug 21, 2026, 3:29 PM IST
Veedol Corporation Revenue
Veedol Corporation had revenue of 6.09B INR in the quarter ending June 30, 2026, with 18.49% growth. This brings the company's revenue in the last twelve months to 22.63B, up 12.85% year-over-year. In the fiscal year ending March 31, 2026, Veedol Corporation had annual revenue of 21.69B with 9.96% growth.
Revenue (ttm)
22.63B
Revenue Growth
+12.85%
P/S Ratio
1.13
Revenue / Employee
45.08M
Employees
502
Market Cap
25.53B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 21.69B | 1.96B | 9.96% |
| Mar 31, 2025 | 19.72B | 395.30M | 2.05% |
| Mar 31, 2024 | 19.33B | 788.10M | 4.25% |
| Mar 31, 2023 | 18.54B | 3.18B | 20.71% |
| Mar 31, 2022 | 15.36B | 2.77B | 22.03% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Savita Oil Technologies | 48.53B |
| Laxmi Organic Industries | 31.22B |
| Rossari Biotech | 25.50B |
| S H Kelkar and Company | 24.49B |
| Jubilant Agri and Consumer Products | 19.72B |
| NOCIL | 13.70B |
| Advanced Enzyme Technologies | 7.50B |
| Jai Corp | 6.07B |